Table 5 Description of studies for the development and validation of interview-administered Past-week and Usual-week physical activity questionnaires
Instrument | Reference | Purpose of study | Study population | Health condition | Age range (R; mean ± standard deviation) |
|---|---|---|---|---|---|
Usual-week Physical Activity Questionnaires | |||||
 CaMos Usual-week | Nadalin, Bentvelsen [45] | To assess test-retest reliability of a portion of the CaMos questionnaire using a combination of administration modes | Reliability (N = 367) | Physical: healthy with possible osteoporosis Cognitive: Not screened | Total sample: R = 45–80 (NR)y |
 IPEQ-WA Usual-week | Merom, Delbaere [46] | Assessed construct validity and responsiveness of IPEQ | Male (I) & Female (II): Validity (N = 40 & 86) | Physical: No chronic disease conditions Cognitive: Healthy based on cognitive test | Total sample: R = NR; (I) NR; (II) NR |
 MAQ Usual-week | Pettee Gabriel, McClain [47] | Test-retest reliability and convergent validity of five PAQs commonly used in larger health studies involving middle-aged women | Female (I): Repeatability & Validity (N = 62–66) | Physical: No chronic disease conditions Cognitive: Not screened | Total sample: R = 45–65 (52.6 ± 5.4)y |
Kriska, Knowler [48] | To examine the reliability and validity of the MAQ | Male (I) & Female (II): Repeatability (N = 69) Validity (N = 21) | Physical: No physical limitations with possible type II diabetes mellitus Cognitive: Not screened | Total sample: R = 10–59 (NR)yr.; (I) 10–59 NR; (II) 10–59 (NR)y | |
Kriska, Edelstein [49] | To compare MAQ with other PAQs among individuals with type 2 diabetes | Male: Validity (I) (N = 1043) Female: Validity (II) (N = 2191) | Physical: No physical limitations with possible type II diabetes mellitus Cognitive: Not screened | Total sample: NR (50.6 ± 10.7)yr.; (I) NR; (II) NR | |
Schulz, Harper [50] | To compare MAQ with direct measures of energy expenditure | Male: Validity (I) (N = 12) Female: Validity (II) (N = 9) | Physical: No physical limitations with possible type II diabetes mellitus Cognitive: Not screened | Total sample: NR; (I) R = NR (35.4 ± 13.8)yr.; (II) R = NR (31.3 ± 13.0)y | |
 NHS II Usual-week | Pettee Gabriel, McClain [47] | As for MAQ | As for MAQ | As for MAQ | As for MAQ |
 Phone-FITT Usual-week | Gill, Jones [51] | To develop the Phone-FITT and to evaluate the test–retest reliability and criterion-related (concurrent) and construct (convergent, discriminant and known-groups) validity | Male: Repeatability (I) & Validity (II) (N = 22 & 12) Female: Repeatability (III) & Validity (IV) (N = 21 & 36) | Physical: No chronic disease conditions Cognitive: Not screened | Total sample: R = 73–87 (79.4 ± 2.9)y; (I) 76–86 (79.4 ± 3.2)y; (II) 72–82 (76.5 ± 3.4); (III) 76–86 (79.5 ± 2.7)y; (IV) 71–89 (77.8 ± 5.1)y |
 YPAS Usual-week | Colbert, Matthews [52] | Compared validity of a variety of physical activity measurement tools in older adults | Validity (N = 56) | Physical: Musculoskeletal conditions, lung disease, cancer and hypertension Cognitive: Not screened | Total sample: R = NR (74.7 ± 6.5)y |
Dipietro, Caspersen [53] | Preliminary repeatability data and validation results relative to selected physiologic variables | Male (I) & Female (II): Repeatability (N = 20 & 56); Validity (N = 14 & 11) | Physical: No chronic disease conditions Cognitive: Not screened | Total sample: R = NR (71.0 ± 6.6)y; (I) R = NR (70.9 ± 6.2)y; (II) R = NR (69.6 ± 6.0)y | |
Gennuso, Matthews [54] | Reliability and validity of physical activity surveys for assessing time spent in sedentary behavior in older adults | Validity & Repeatability (N = 58) | Physical: NR Cognitive: Not screened | Total sample: R = 66–88 (75.1 ± 6.5)y | |
Harada, Chiu [55] | Assess the known-groups and construct validity of CHAMPS, PASE and YPAS | Retirement homes (I) & Community centres (II): Validity (N = 36 & 51) | Physical: Musculoskeletal conditions, lung disease, diabetes and hypertension Cognitive: Healthy based on cognitive test | Total sample: R = 56–89 (75.0 ± 6.0); (I) R = 65–89 (79.0 ± 6.0); (II) R = 65–86 (73.0 ± 5.0) | |
Kolbe-Alexander, Lambert [56] | Validity and reliability of the YPAS and the short version of the IPAQ in older South African adults | Male (I) & Female (II): (N = 52 & 70); Sample (N) not reported between psychometric measures | Physical: NR Cognitive: Not screened | Total sample: R = 62–69 (66 ± NR)y; (I) 62–69 (67 ± NR); (II) 62–69 (65 ± NR) | |
Moore, Ellis [57] | Construct validity of four PAQs in culturally diverse older adults | African American (I) & Caucasian (II): Validity (N = 54) | Physical: Musculoskeletal conditions, neurological and cardiorespiratory Cognitive: Healthy based on cognitive test | Total sample: NR; (I) NR (67.2 ± 9.9)y; (II) NR (66.3 ± 9.8)y | |
Past-week Physical Activity Questionnaires | |||||
 AAS Past-7 days | Brown, Trost [58] | Assessed the test-retest reliability of activity status derived from four physical activity measures | AAS (I), IPAQ (II), BRFSS (III) & NHS (IV): Repeatability (N = 356, 104, 127 & 122) | Physical: NR Cognitive: Not screened | Total sample: R = 18-75y (NR)y; (I), (II), (III) & (IV) 18-75y (NR)y |
Brown, Bauman [59] | Compared the level of agreement in prevalence estimates of the proportion of the population that is sufficiently active for health benefit derived from four measures that are in use in Australia and elsewhere around the world | AAS (I), IPAQ (II) & BRFSS (III): Validity (N = 428, 427 & 425) | Physical: NR Cognitive: Not screened | Total sample: R = 18-75y (NR)y; (I), (II) & (III) 18-75y (NR)y | |
|  | Creamer, Bowles [60] | Determining computer-assisted approaches for surveillance of physical activity | Validity & Repeatability (N = 56) | Physical: NR Cognitive: Screened based on capability to read | Total sample: NR (43.1 ± 11.4)y |
 AAS (modified) Past-7 days | Fjeldsoe, Winkler [18] | Determined the test–retest reliability and criterion validity the Adapted Active Australia Survey and whether these properties varied across participants’ activity levels | Validity & Repeatability (N = 63) | Physical: NR Cognitive: Screened based on capability to read | Total sample: NR (49.5 ± 12.5)y |
 CAQ-PAI Past-7 days | Mahabir, Baer [61] | Convergent validity of four physical activity questionnaires with DLW | Validity (N = 65) | Physical: No chronic disease conditions Cognitive: Not screened | Total sample: 49.2–78.8 (59.9 ± 7.5)y |
Rauh, Hovell [62] | Reliability and convergent validity of several PAQs | Validity (N = 45) | Physical: NR Cognitive: Not screened | Total sample: 18–55 (33.0 ± 10.6)y | |
Washburn, Smith [63] | Reliability of the CAQ-PAI | Combined gender (I), Male (II) & Female (III): Repeatability (N = 633, 261 & 372) | Physical: No chronic disease conditions Cognitive: Not screened | (I) Total sample: 25–65: (39.5 ± 10.8)y; (II) NR (38.2 ± 10.6)y; (III) NR (40.5 ± 10.8) | |
 Checklist Questionnaire Past-7 days | Masse, Fulton [64] | Compared the validity of two physical activity questionnaire formats | Validity (N = 260) | Physical: NR Cognitive: Not screened | Total sample: R = 40–70 (49.2 ± 7.0)y |
 Global Questionnaire Past-7 days | Masse, Fulton [64] | As per Checklist Questionnaire | As per Checklist Questionnaire | As per Checklist Questionnaire | As per Checklist Questionnaire |
 IPAQ-LF Past-7 days | Ahn, Chmiel [65] | Validity of IPAQ-SF (telephone) with accelerometer amongst adults with systemic lumpus erythematosus | Validity (N = 118) | Physical: Systemic Lupus Erythematosus Cognitive: Not screened | Total sample: NR (45.4 ± 10.9)y |
Garriguet, Tremblay [66] | Validity of IPAQ-LF (self-administered) and the new Physical Activity for Adults Questionnaire (PAAQ) with accelerometers | IPAQ-LF (I) & PAAQ (II): Validity (N = 94 & 108) | Physical: NR Cognitive: Healthy based on cognitive interview | Total sample: 18–79 (NR); (I) NR (47 ± NR)y; (II) NR (47 ± NR)y | |
 IPAQ-SF Past-7 days | Ainsworth, Macera [67] | Compared the physical activity prevalence estimates obtained from BRFSS and IPAQ-SF (interview) | Validity (N = 9945) | Physical: Non-institutionalised Cognitive: Non-institutionalised | Total sample: R = 18–55+ (NR) |
Brown, Trost [58] | As for AAS | As for AAS | As for AAS | As for AAS | |
Brown, Bauman [59] | As for AAS | As for AAS | As for AAS | As for AAS | |
 NZPAQ-LF Past-7 days | Moy, Scragg [68] | Convergent validity of NZPAQ-LF with heart-rate monitoring | Male (I) & Female (II): Validity (N = 90 & 96) | Physical: NR Cognitive: Not screened | Total sample: 19–86 (48.6 ± 16.4)y; (I) NR (48.4 ± NR)y; (II) NR (48.7 ± NR)y |
 NZPAQ-SF Past-7 days | Moy, Scragg [68] | As per NZPAQ-LF | As per NZPAQ-LF | As per NZPAQ-LF | As per NZPAQ-LF |
 PAAQ Past-7 days | Garriguet, Tremblay [66] | As for IPAQ-LF | As for IPAQ-LF | As for IPAQ-LF | As for IPAQ-LF |
 PASE Past-7 days | Colbert, Matthews [52] | As for YPAS | As for YPAS | As for YPAS | As for YPAS |
Dinger, Oman [69] | Convergent validity and reliability of PASE with accelerometers with elderly individuals | Validity & Repeatability (N = 56) | Physical: NR Cognitive: Not screened | Total sample: NR (75.7 ± 7.9)y | |
Johansen, Painter [70] | Convergent validity of three physical activity questionnaires with accelerometers in patients with end-stage renal disease | Validity (N = 39) | Physical: Patients undergoing haemodialysis Cognitive: Not screened | Total sample: NR (52 ± 16)y | |
Moore, Ellis [57] | As for YPAS | As for YPAS | As for YPAS | As for YPAS | |
Washburn, Smith [71] | Convergent validity and reliability of PASE with accelerometers | Validity & Repeatability (N = 119) | Physical: Included participants without serious physical impairments Cognitive: Included participants without serious cognitive impairments, but screening method not clear | Total sample: NR (73.4 ± NR)y | |
 PWMAQ Past-7 days | Pettee Gabriel, McClain [72] | Reliability and validity of PWMAQ in middle-aged women | Validity & Repeatability (N = 66) | Physical: NR Cognitive: Not screened | Total sample: NR (52.6 ± 5.4)y |
Pettee Gabriel, McClain [47] | As for MAQ | As for MAQ | As for MAQ | As for MAQ | |
 PAR Past-7 days | Albanes, Conway [73] | As for CAQ-PAI | As for CAQ-PAI | As for CAQ-PAI | As for CAQ-PAI |
Blair, Haskell [74] | Construct validity of PAR | Male (I) & Female (II): Validity (N = 1077, 1206) | Physical: NR Cognitive: Not screened | Total sample: 16–74 (NR)y | |
Conway, Seale [75] | Convergent validity of PAR with DLW | Validity (N = 24) | Physical: No chronic disease conditions Cognitive: Not screened | Total sample: 27–65 (41.2 ± 2.0)y | |
Garfield, Canavan [76] | As for PASE | As for PASE | As for PASE | As for PASE | |
Gross, Sallis [77] | Inter-rater reliability of PAR | Inter-rater reliability (N = 21) | Physical: NR Cognitive: Not screened | Total sample: 19–52 (NR)y | |
Irwin, Ainsworth [78] | Convergent validity of PAR with DLW | Validity (N = 24) | Physical: No chronic disease conditions Cognitive: Not screened | Total sample: 27–65 (41.2 ± 9.6)y | |
Johansen, Painter [70] | As for PASE | As for PASE | As for PASE | As for PASE | |
Mahabir, Baer [61] | As for CAQ-PAI | As for CAQ-PAI | As for CAQ-PAI | As for CAQ-PAI | |
Rauh, Hovell [62] | As for CAQ-PAI | As for CAQ-PAI | As for CAQ-PAI | As for CAQ-PAI | |
Sallis, Haskell [79] | Reliability of PAR | Repeatability (N = 64) | Physical: NR Cognitive: Not screened | Total sample: 20–74 (40.1 ± 15.7)y | |
Sarkin, Johnson [33] | Construct validity of three physical activity questionnaires | Combined gender (I), Male (II) & Female (III): Validity (N = 575, 256 & 319) | Physical: NR Cognitive: Not screened | (I) Total sample: NR (24.5 ± 1.9)y; (II) NR (24.7 ± 2.0)y; (III) NR (24.4 ± 2.1)y | |
Taylor, Coffey [80] | Convergent validity of PAR with motion sensors | Validity (N = 30) | Physical: Some patients with myocardial infarction several 11–26 weeks prior to study Cognitive: Not screened | Total sample: 34–69 (52.3 ± NR) | |
Washburn, Jacobsen [81] | Convergent validity of PAR with DLW | Male (I) & Female (II): Validity (N = 17 & 29) | Physical: No chronic disease conditions Cognitive: Not screened | Total sample: 17–35 (23.6 ± 4.2)y; (I) NR (23.9 ± 3.8)y; (II) NR (23.3 ± 4.6)y | |
Williams, Klesges [82] | Reliability and convergent validity of PAR in college students | Repeatability & Validity (N = 45) | Physical: NR Cognitive: Not screened, but were all enrolled at a university | Total sample: 18–52 (24.7 ± 7.73)y | |
 VAPAQ Past-7 days | Betz, Myers [83] | Reproducibility of VAPAQ in an elderly population | Exercise group (I) & Usual care group (II): Repeatability (N = 26 & 29)y | Physical: All patients had abdominal aortic aneurysm Cognitive: Not screened | Total sample: NR (73.0 ± 7.9)y; (I) NR; (II) NR |